{
    "clinical_study": {
        "@rank": "57150", 
        "acronym": "DOSE-HD", 
        "arm_group": [
            {
                "arm_group_label": "End Stage Renal Disease", 
                "description": "GFR 15 ml/min or less or on Dialysis"
            }, 
            {
                "arm_group_label": "Chronic Kidney Disease Stage 4", 
                "description": "GFR 15-30 ml/min"
            }, 
            {
                "arm_group_label": "Chronic Kidney Disease Stage -3", 
                "description": "GFR 30-60 ml/min"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess whether the current recommendation for a 50% dose\n      reduction in insulin for diabetic patients with a creatinine clearance (CrCl) \u226415 mL/min or\n      on hemodialysis results in an increased number of hypoglycemic episodes."
        }, 
        "brief_title": "Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Hypoglycemia", 
            "Renal Dysfunction", 
            "Insulin Dosing"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Hypoglycemia", 
                "Kidney Diseases", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Inpatient men and women 18 years of age and older with a diagnosis of type 2 diabetes\n             mellitus (T2DM) with CrCl \u226560, 16-59 or \u226415 milliliters/minute.\n\n        Exclusion Criteria:\n\n          -  Patients less than 18 years of age, pregnant patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "In patient hospitalized greater than or equal to three days, diabetic with CKD 3-5 or on\n        dialysis on insulin therapy"
            }
        }, 
        "enrollment": {
            "#text": "496", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02083133", 
            "org_study_id": "13-188"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Diabetes", 
            "Renal Failure", 
            "Dialysis", 
            "End Stage Renal Disease", 
            "Hypoglycemia"
        ], 
        "lastchanged_date": "March 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60612"
                }, 
                "name": "John H Stroger Hospital of Cook County"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Dosing Strategies in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis (DOSE-HD Study)", 
        "overall_official": {
            "affiliation": "Cook County Hospital", 
            "last_name": "Pete Antonopoulos, PharmD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hypoglycemia", 
            "safety_issue": "Yes", 
            "time_frame": "Last 5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02083133"
        }, 
        "responsible_party": {
            "investigator_affiliation": "John H. Stroger Hospital", 
            "investigator_full_name": "Pete Antonopoulos", 
            "investigator_title": "Clinical Pharmacist- Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "John H. Stroger Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "John H. Stroger Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}